Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Ho: Enhancing Innate Immune Activation |
| Strategy: | Prophylactic neutralizing Ab |
| Study Type: | Antibody Screening |
| Species: | Non-Organism Study |
| Stage: | Assays Completed |
| Study Start Date: | 2007-09-05 |
| Study Made Public: | 2011-02-25 |
Title
Screen for broadly neutralizing sera among Dr. Bruce Walker’s Massachusetts General Hospital HIV+ Patient Cohort in Boston [Original Study Title: Walker 1 and Walker 2]
Description
CAVD 290 is an immunogenicity study to evaluate and characterize the neutralization activity of broadly neutralizing antibodies from humans in HIV controllers.
Sign in to see full information about this study and to download study data.
Products
No Products used in studyIntegrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.